ArticleJournal of gastroenterology2025

Circulating miR-485-3p as a biomarker for VEGF-associated therapeutic response to atezolizumab plus bevacizumab in hepatocellular carcinoma.

Kyoko Oura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.